AllianceBernstein’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $21M | Buy |
123,716
+27,353
| +28% | +$4.78M | 0.01% | 896 |
|
|
2025
Q4 | $16.4M | Sell |
96,363
-30,885
| -24% | -$4.73M | 0.01% | 1040 |
|
|
2025
Q3 | $16.8M | Sell |
127,248
-17,036
| -12% | -$2.04M | 0.01% | 994 |
|
|
2025
Q2 | $15.3M | Buy |
144,284
+26,335
| +22% | +$2.86M | 0.01% | 1007 |
|
|
2025
Q1 | $14.6M | Buy |
117,949
+29,578
| +33% | +$3.86M | 0.01% | 984 |
|
|
2024
Q4 | $10.9M | Sell |
88,371
-11,577
| -12% | -$1.36M | ﹤0.01% | 1149 |
|
|
2024
Q3 | $11.1M | Buy |
99,948
+11,294
| +13% | +$1.24M | ﹤0.01% | 1132 |
|
|
2024
Q2 | $9.46M | Sell |
88,654
-16,556
| -16% | -$1.82M | ﹤0.01% | 1192 |
|
|
2024
Q1 | $12.7M | Sell |
105,210
-1,479
| -1% | -$181K | ﹤0.01% | 1047 |
|
|
2023
Q4 | $13.1M | Buy |
106,689
+2,789
| +3% | +$348K | 0.01% | 1029 |
|
|
2023
Q3 | $13.4M | Sell |
103,900
-6,980
| -6% | -$930K | 0.01% | 978 |
|
|
2023
Q2 | $13.7M | Buy |
110,880
+12,170
| +12% | +$1.64M | 0.01% | 990 |
|
|
2023
Q1 | $14.4M | Buy |
98,710
+519
| +0.5% | +$76.8K | 0.01% | 957 |
|
|
2022
Q4 | $15.6M | Sell |
98,191
-27,510
| -22% | -$4.03M | 0.01% | 905 |
|
|
2022
Q3 | $16.8M | Sell |
125,701
-9,641
| -7% | -$1.47M | 0.01% | 888 |
|
|
2022
Q2 | $21.1M | Buy |
135,342
+40,150
| +42% | +$6.18M | 0.01% | 848 |
|
|
2022
Q1 | $14.8M | Sell |
95,192
-1,197
| -1% | -$174K | 0.01% | 1045 |
|
|
2021
Q4 | $12.3M | Sell |
96,389
-13,240
| -12% | -$1.74M | ﹤0.01% | 1140 |
|
|
2021
Q3 | $14.3M | Buy |
109,629
+15,272
| +16% | +$2.31M | 0.01% | 1064 |
|
|
2021
Q2 | $16.8M | Sell |
94,357
-24,825
| -21% | -$4.3M | 0.01% | 1015 |
|
|
2021
Q1 | $19.6M | Buy |
119,182
+28,009
| +31% | +$4.61M | 0.01% | 933 |
|
|
2020
Q4 | $15M | Sell |
91,173
-2,008
| -2% | -$299K | 0.01% | 954 |
|
|
2020
Q3 | $13.3M | Buy |
93,181
+60,867
| +188% | +$7.55M | 0.01% | 938 |
|
|
2020
Q2 | $3.57M | Sell |
32,314
-2,333
| -7% | -$258K | ﹤0.01% | 1522 |
|
|
2020
Q1 | $3.46M | Sell |
34,647
-6,315
| -15% | -$816K | ﹤0.01% | 1355 |
|
|
2019
Q4 | $6.12M | Buy |
40,962
+5,698
| +16% | +$775K | ﹤0.01% | 1311 |
|
|
2019
Q3 | $4.52M | Buy |
35,264
+1,141
| +3% | +$153K | ﹤0.01% | 1448 |
|
|
2019
Q2 | $4.87M | Sell |
34,123
-47,341
| -58% | -$6.36M | ﹤0.01% | 1432 |
|
|
2019
Q1 | $11.6M | Buy |
81,464
+46,146
| +131% | +$6.02M | 0.01% | 989 |
|
|
2018
Q4 | $4.38M | Sell |
35,318
-25,266
| -42% | -$3.75M | ﹤0.01% | 1364 |
|
|
2018
Q3 | $10.2M | Buy |
60,584
+3,805
| +7% | +$654K | 0.01% | 972 |
|
|
2018
Q2 | $9.78M | Buy |
56,779
+54,296
| +2,187% | +$8.88M | 0.01% | 975 |
|
|
2018
Q1 | $375K | Hold |
2,483
| – | – | ﹤0.01% | 2619 |
|
|
2017
Q4 | $334K | Hold |
2,483
| – | – | ﹤0.01% | 2679 |
|
|
2017
Q3 | $363K | Sell |
2,483
-1,869
| -43% | -$283K | ﹤0.01% | 2689 |
|
|
2017
Q2 | $677K | Buy |
4,352
+141
| +3% | +$21.6K | ﹤0.01% | 2487 |
|
|
2017
Q1 | $611K | Buy |
4,211
+684
| +19% | +$89.1K | ﹤0.01% | 2469 |
|
|
2016
Q4 | $385K | Buy |
3,527
+80
| +2% | +$8.91K | ﹤0.01% | 2651 |
|
|
2016
Q3 | $419K | Hold |
3,447
| – | – | ﹤0.01% | 2589 |
|
|
2016
Q2 | $487K | Sell |
3,447
-38,573
| -92% | -$5.69M | ﹤0.01% | 2528 |
|
|
2016
Q1 | $5.49M | Sell |
42,020
-2,365
| -5% | -$294K | ﹤0.01% | 1023 |
|
|
2015
Q4 | $6.24M | Sell |
44,385
-195,032
| -81% | -$27M | 0.01% | 992 |
|
|
2015
Q3 | $31.8M | Sell |
239,417
-287,797
| -55% | -$49.6M | 0.03% | 543 |
|
|
2015
Q2 | $92.8M | Sell |
527,214
-142,904
| -21% | -$25.7M | 0.08% | 279 |
|
|
2015
Q1 | $116M | Sell |
670,118
-46,565
| -6% | -$7.99M | 0.09% | 233 |
|
|
2014
Q4 | $117M | Buy |
716,683
+594
| +0.1% | +$98.6K | 0.1% | 222 |
|
|
2014
Q3 | $115M | Buy |
716,089
+19,442
| +3% | +$2.99M | 0.1% | 217 |
|
|
2014
Q2 | $102M | Buy |
696,647
+32,500
| +5% | +$4.51M | 0.09% | 258 |
|
|
2014
Q1 | $92.1M | Sell |
664,147
-553,154
| -45% | -$83.3M | 0.08% | 283 |
|
|
2013
Q4 | $154M | Sell |
1,217,301
-175,366
| -13% | -$18.1M | 0.14% | 173 |
|
|
2013
Q3 | $128M | Sell |
1,392,667
-127,953
| -8% | -$10.3M | 0.13% | 177 |
|
|
2013
Q2 | $105M | Buy |
+1,520,620
| New | +$92.9M | 0.11% | 203 |
|
Other funds holding JAZZ
VPM
VCM
EC
AllianceBernstein's JAZZ Position: Q1 2026 in Review
AllianceBernstein increased its Jazz Pharmaceuticals (JAZZ) stake by 28% in Q1 2026, buying an estimated $4.78M and bringing the position to 123,716 shares worth $21M. The position accounts for 0.01% of the portfolio, ranked #896.
AllianceBernstein first reported a position in JAZZ in Q2 2013 and has held it in 52 quarters since. The position peaked at $154M in Q4 2013. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- AllianceBernstein held 123,716 shares of Jazz Pharmaceuticals worth $21M as of Q1 2026.
- AllianceBernstein bought 27,353 Jazz Pharmaceuticals shares in Q1 2026, an estimated $4.78M.
- Jazz Pharmaceuticals made up 0.01% of AllianceBernstein's portfolio in Q1 2026, its #896 holding.
- AllianceBernstein first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 52 quarters since.
- AllianceBernstein's Jazz Pharmaceuticals position peaked at $154M in Q4 2013.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.